{"filing":{"accession_number":"0001720580-26-000043","cik":"0001720580","ticker":"ACET","company_name":"Adicet Bio, Inc.","form":"8-K","filing_date":"2026-06-18","report_date":null,"primary_document":"acet-20260617.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1720580/000172058026000043/acet-20260617.htm"},"events":[{"id":11791,"run_id":10370,"accession_number":"0001720580-26-000043","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear Item 5.07 disclosure of shareholder vote results from Adicet Bio's June 17, 2026 Annual Meeting of Stockholders. The filing reports final voting tallies for three proposals: election of Class II directors (Chodakewitz, Dubin, Grissinger), non-binding advisory vote on named executive officer compensation, and ratification of KPMG LLP as independent auditor. All three proposals passed with substantial majorities, making this a routine but material governance disclosure that affects investor understanding of board composition and audit oversight.","company_name":"Adicet Bio, Inc.","ticker":"ACET","filing_date":"2026-06-18","form":"8-K","submitted_at":null,"items":[{"id":8468,"accession_number":"0001720580-26-000043","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear Item 5.07 disclosure of shareholder vote results from Adicet Bio's June 17, 2026 Annual Meeting of Stockholders. The filing reports final voting tallies for three proposals: election of Class II directors (Chodakewitz, Dubin, Grissinger), non-binding advisory vote on named executive officer compensation, and ratification of KPMG LLP as independent auditor. All three proposals passed with substantial majorities, making this a routine but material governance disclosure that affects investor understanding of board composition and audit oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:04:25.190713+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8468,"accession_number":"0001720580-26-000043","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear Item 5.07 disclosure of shareholder vote results from Adicet Bio's June 17, 2026 Annual Meeting of Stockholders. The filing reports final voting tallies for three proposals: election of Class II directors (Chodakewitz, Dubin, Grissinger), non-binding advisory vote on named executive officer compensation, and ratification of KPMG LLP as independent auditor. All three proposals passed with substantial majorities, making this a routine but material governance disclosure that affects investor understanding of board composition and audit oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:04:25.190713+00:00","company_name":"Adicet Bio, Inc.","ticker":"ACET","filing_date":"2026-06-18"}]}